Your browser doesn't support javascript.
loading
Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum.
Noureddin, Mazen; Chan, Jean L; Barradas, Katherine; Dimick-Santos, Lara; Schabel, Elmer; Omokaro, Stephanie O; Anania, Frank A; Myers, Robert P; Miller, Veronica; Sanyal, Arun J; Chalasani, Naga.
Affiliation
  • Noureddin M; Cedars Sinai Medical Center, Los Angeles, California.
  • Chan JL; Conatus Pharmaceuticals, San Diego, California.
  • Barradas K; University of California, Berkeley, California.
  • Dimick-Santos L; US Food and Drug Administration, Silver Spring, Maryland.
  • Schabel E; Bundesinstitut fuer Arzneimittel und Medizinprodukte, Bonn, Germany.
  • Omokaro SO; US Food and Drug Administration, Silver Spring, Maryland.
  • Anania FA; US Food and Drug Administration, Silver Spring, Maryland.
  • Myers RP; Gilead Sciences, Inc., Foster City, California.
  • Miller V; University of California, Berkeley, California.
  • Sanyal AJ; Virginia Commonwealth University, Richmond, Virginia.
  • Chalasani N; Indiana University School of Medicine, Indianapolis, Indiana.
Gastroenterology ; 159(2): 422-427.e1, 2020 08.
Article in En | MEDLINE | ID: mdl-32353369

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Practice Guidelines as Topic / Patient Selection / Non-alcoholic Fatty Liver Disease / Liver Cirrhosis Type of study: Etiology_studies / Guideline Limits: Humans Language: En Journal: Gastroenterology Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Practice Guidelines as Topic / Patient Selection / Non-alcoholic Fatty Liver Disease / Liver Cirrhosis Type of study: Etiology_studies / Guideline Limits: Humans Language: En Journal: Gastroenterology Year: 2020 Document type: Article